课题基金 / 基金详情

Biomarkers for prognosis of closed-mechanism nerve injuries

Biomarkers for prognosis of closed-mechanism nerve injuries
闭合性神经损伤预后的生物标志物
批准号:
10742745
负责人:
MARK MAHAN
金额:
$44.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-05-31
关键词:
AddressApraxiasArea Under CurveBiological AssayBiological MarkersBiologyBiomechanicsBloodCategoriesCicatrixClinicalClinical ManagementClinical ResearchComplexCrush InjuryDataData SetDiagnosisDiagnosticDiagnostic testsEarly DiagnosisEarly InterventionElasticityEsthesiaEvaluationEvidence based interventionExpert OpinionFailureFunctional disorderFutureGoalsGrowthHealth Care CostsHistologyHospitalizationHourHumanIndividualInjuryLaboratory StudyLeadLimb structureMachine LearningMethodologyMethodsModelingMovementMultiple TraumaMuscular AtrophyNatural regenerationNerveNerve RegenerationNerve TissueNervous System TraumaNeurological outcomeNeuromaOperative Surgical ProceduresOutcomePainPathway interactionsPatientsPatternPerformancePeripheral nerve injuryPhysiciansPlasmaPovertyPrognosisPropertyProteinsProteomicsQualifyingRNARecommendationRecoveryResearchRodentRuptureSeveritiesSpecificityStretchingTechniquesTestingTimeTissuesValidationWorkaxon injurybiomarker identificationbiomarker signaturebiomarker validationblood-based biomarkerclinically relevantdesigndiagnostic accuracydiagnostic tooldiagnostic valueevidence baseextracellularfunctional losshealingimprovedlarge datasetsloss of functionmRNA Expressionmachine learning algorithmmolecular markernerve injurynovelperipheral bloodpointed proteinproductivity lossprognosis biomarkerprognosticprognostic valueprogramsprotein biomarkersreconstructionregenerativereinnervationrepairedresearch clinical testingresponserestorationsenescencespecific biomarkersspinal cord and brain injurysuccesssurgery outcometooltranscriptome sequencingtranscriptomics

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT / PROJECT SUMMARY Closed-mechanism peripheral nerve injuries are among the most devastating neurologic injuries, often with complete loss of functional use of a limb. Nerve regeneration, i.e., the cascade of regenerative changes after injury, commonly fails in rapid-stretch injuries. Instead, a neuroma forms – where abundant scar tissue replaces the normal pathway for nerve regeneration. Unfortunately, in closed-mechanism injuries, there are few diagnostic clues to identify when neuromas will form – and thus, clinical management is based on waiting until failure is manifest – and the surgical outcomes are, consequentially, impoverished due to regenerative senescence. The goal of this project is to test the hypotheses that there are biomarkers in peripheral blood to provide prognosis and guide the management of closed mechanism nerve injuries. Neurological outcomes are clearly related to the 1) severity of nerve injury and to 2) healing response, whether regeneration or neuroma formation. We have established a rapid-stretch nerve injury model that mimics, along with crush injuries, the clinically relevant closed-mechanism nerve injuries. Our model matches the injury types/grades and histology seen in human nerve injuries. We propose utilizing both circulating protein and RNA molecules, to remain unbiased in selecting the optimal diagnostic tool for the future. Machine learning algorithms will be applied to the large dataset to improve diagnostic accuracy. If successful, this project will provide preliminary data for designing future human trials aimed at evaluating nerve injuries (R61/R33). Specifically, we will need to know whether proteomics or transcriptomics or a combination will provide greater diagnostic accuracy, as well as developing workflow for machine learning algorithms. The proposed evaluation will likely provide significant clinical utility in proximal nerve injuries, where the prognosis for recovery is currently poor due to the prolonged time required to detect failed regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金